Neurology News

In his keynote address at this year’s Ending Clinician Burnout Global Summit, Thom Mayer, MD, FACEP, likened the health care practitioners in the audience to the professional football players he routinely treats.

In two large trials of individuals with Parkinson’s disease, dementia occurred less frequently and later in the disease course than previously thought, according to new research published in Neurology.

The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.

As medical technology quickly evolves, practices in nearly all areas of medicine must frequently evaluate equipment upgrades and new purchases of new technology to stay at the forefront of patient care.

ORLANDO, Fla. — Although rheumatic diseases must be considered in a differential diagnosis of autoimmune encephalitis, some patients can have both, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.

A Maryland-based neurotechnology company has secured a U.S. patent for its novel prosthetic translucent, cranial implant intended for use during neurosurgical procedures.

Most clinicians expressed positive attitudes and increased knowledge about climate change and health following the completion of a quality incentive program, researchers found.

The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, according to the manufacturer.

Over 150 minutes of aerobic exercise a week following a concussion improved sleep quality in adolescents, study results published in The Journal of Head Trauma Rehabilitation showed.

The FDA has granted rare pediatric disease designation to an investigational oligonucleotide for the treatment of boys with Duchenne muscular dystrophy who are amenable to exon 53 skipping, according to the manufacturer.